Search Results

Alcami Corporation (“Alcami”), a leading contract development and manufacturing organization (CDMO), today announced a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services.

Alcami Corporation, a leading contract development and manufacturing organization, announced the appointment of Rose-Marie Nelson as Chief Human Resources Officer.

Alcami Corporation announced it has completed the acquisition of Pacific Pharmaceutical Services, Inc., a preferred provider of cGMP pharma storage and services.

Alcami Corporation announced the strategic expansion of its sterile fill/finish manufacturing capacity with the addition of a new sterile fill/finish line with isolator and two lyophilizers at its existing Charleston, SC manufacturing campus.

Alcami Corporation announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.

Cytovance Biologics has announced a strategic collaboration with fellow CDMO Alcami Corporation to expand its large molecule biologic manufacturing and sterile fill finish offering.

Alcami Corporation, a leading contract development and manufacturing organization, announced the appointment of Tariq Jamal to Chief Information Officer.

Alcami Corporation (“Alcami”) today welcomed the recent announcement by Nectero Medical that they have received clearance from the U.S. Food and Drug Administration of their IND application to initiate Phase II/III trial of the Nectero Endovascular Aneurysm Stabilization Treatment (EAST®) System for the treatment of small- to-mid-sized abdominal aortic aneurysms (AAA).

Alcami Corporation, a leading contract development and manufacturing organization, announced the retirement of Patrick Walsh and the subsequent appointment of Bill Humphries as the next CEO, effective June 5th, 2023.